KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nutanix (NTNX) over the last 11 years, with Q4 2025 value amounting to $780.4 million.

  • Nutanix's Cash & Equivalents rose 890.55% to $780.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $780.4 million, marking a year-over-year increase of 890.55%. This contributed to the annual value of $769.5 million for FY2025, which is 1736.26% up from last year.
  • According to the latest figures from Q4 2025, Nutanix's Cash & Equivalents is $780.4 million, which was up 890.55% from $769.5 million recorded in Q3 2025.
  • Nutanix's 5-year Cash & Equivalents high stood at $872.6 million for Q1 2025, and its period low was $274.7 million during Q2 2021.
  • For the 5-year period, Nutanix's Cash & Equivalents averaged around $536.2 million, with its median value being $496.8 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3042.67% in 2021, then soared by 4760.37% in 2024.
  • Quarter analysis of 5 years shows Nutanix's Cash & Equivalents stood at $351.0 million in 2021, then skyrocketed by 36.93% to $480.6 million in 2022, then rose by 27.43% to $612.5 million in 2023, then grew by 17.0% to $716.6 million in 2024, then increased by 8.91% to $780.4 million in 2025.
  • Its Cash & Equivalents was $780.4 million in Q4 2025, compared to $769.5 million in Q3 2025 and $872.6 million in Q2 2025.